Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06183489 |
| Title | Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma (ERASMM) |
| Acronym | ERASMM |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | European Myeloma Network |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | NOR | NLD | ITA | GRC | FRA | FIN |